Eli Lilly and CompanyEli Lilly and CompanyEli Lilly and Company

Eli Lilly and Company

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪693.36 B‬USD
15.105USD
‪10.59 B‬USD
‪45.04 B‬USD
‪848.58 M‬
Beta (1Y)
0.65
Employees (FY)
‪47 K‬
Change (1Y)
‪+4 K‬ +9.30%
Revenue / Employee (1Y)
‪958.36 K‬USD
Net income / Employee (1Y)
‪225.32 K‬USD

About Eli Lilly and Company


CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
US5324571083
FIGI
BBG01QVYRKH0
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Check out other big names from the same industry as LLY.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
LLY5546986
Eli Lilly and Company 4.7% 27-FEB-2033
Yield to maturity
Maturity date
Feb 27, 2033
LLY5750407
Eli Lilly and Company 4.5% 09-FEB-2027
Yield to maturity
Maturity date
Feb 9, 2027
LLY.GV
Eli Lilly and Company 5.5% 15-MAR-2027
Yield to maturity
Maturity date
Mar 15, 2027
LLY6153507
Eli Lilly and Company 4.25% 15-MAR-2031
Yield to maturity
Maturity date
Mar 15, 2031
LLY4492876
Eli Lilly and Company 3.1% 15-MAY-2027
Yield to maturity
Maturity date
May 15, 2027
LLY6153504
Eli Lilly and Company 4.55% 15-OCT-2032
Yield to maturity
Maturity date
Oct 15, 2032
LLY.HW
Eli Lilly and Company 5.95% 15-NOV-2037
Yield to maturity
Maturity date
Nov 15, 2037
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045
Yield to maturity
Maturity date
Mar 1, 2045
LLY5871809
Eli Lilly and Company 4.15% 14-AUG-2027
Yield to maturity
Maturity date
Aug 14, 2027
LLY6153506
Eli Lilly and Company 4.0% 15-OCT-2028
Yield to maturity
Maturity date
Oct 15, 2028
LLY5871810
Eli Lilly and Company 4.2% 14-AUG-2029
Yield to maturity
Maturity date
Aug 14, 2029

See all LLY bonds 

Frequently Asked Questions


The current price of LLY is 730.230 USD — it has increased by 1.75% in the past 24 hours. Watch Eli Lilly and Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange Eli Lilly and Company stocks are traded under the ticker LLY.
LLY stock has risen by 2.92% compared to the previous week, the month change is a −4.02% fall, over the last year Eli Lilly and Company has showed a −19.58% decrease.
We've gathered analysts' opinions on Eli Lilly and Company future price: according to them, LLY price has a max estimate of 1,190.00 USD and a min estimate of 700.00 USD. Watch LLY chart and read a more detailed Eli Lilly and Company stock forecast: see what analysts think of Eli Lilly and Company and suggest that you do with its stocks.
LLY reached its all-time high on Sep 16, 2024 with the price of 925.000 USD, and its all-time low was 632.010 USD and was reached on Aug 8, 2025. View more price dynamics on LLY chart.
See other stocks reaching their highest and lowest prices.
LLY stock is 1.72% volatile and has beta coefficient of 0.65. Track Eli Lilly and Company stock price on the chart and check out the list of the most volatile stocks — is Eli Lilly and Company there?
Today Eli Lilly and Company has the market capitalization of ‪693.36 B‬, it has decreased by −1.12% over the last week.
Yes, you can track Eli Lilly and Company financials in yearly and quarterly reports right on TradingView.
Eli Lilly and Company is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 6.31 USD per share, whereas the estimation was 5.60 USD resulting in a 12.70% surprise. The estimated earnings for the next quarter are 6.36 USD per share. See more details about Eli Lilly and Company earnings.
Eli Lilly and Company revenue for the last quarter amounts to ‪15.56 B‬ USD, despite the estimated figure of ‪14.70 B‬ USD. In the next quarter, revenue is expected to reach ‪16.04 B‬ USD.
LLY net income for the last quarter is ‪5.66 B‬ USD, while the quarter before that showed ‪2.76 B‬ USD of net income which accounts for 105.14% change. Track more Eli Lilly and Company financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.50 USD. As of today, Dividend Yield (TTM)% is 0.79%. Tracking Eli Lilly and Company dividends might help you take more informed decisions.
Eli Lilly and Company dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 2, 2025, the company has ‪47 K‬ employees. See our rating of the largest employees — is Eli Lilly and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eli Lilly and Company EBITDA is ‪24.33 B‬ USD, and current EBITDA margin is 41.75%. See more stats in Eli Lilly and Company financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eli Lilly and Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eli Lilly and Company technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eli Lilly and Company stock shows the strong sell signal. See more of Eli Lilly and Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.